- Papers in database
- 21
- Years active
- 2020 – 2026
Papers (21)
- 2026CYFRA 21-1 as a circulating biomarker in non-small cell lung cancer.10.1016/j.cca.2026.120910
- 2026Urolithin A: A Novel Postbiotic for inflammation, aging, and cancer: A Journey from Dietary ellagitannins to clinical use.10.1007/s11033-026-11950-4
- 2026Advocating gut-retina connection and microbiota mediated pathways in management of age-related macular degeneration: Preclinical to clinical perspective.10.1016/j.arr.2026.103071
- 2025Diabetic Cardiomyopathy: An Update on Emerging Pathological Mechanisms.10.2174/011573403x331870241025094307
- 2025Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging.10.1007/s10787-025-02001-8
- 2025Natural sesquiterpene lactones in prostate cancer therapy: mechanisms and sources.10.1007/s12032-025-02740-2
- 2025Harnessing therapeutic potential of bromelain and its nanoformulations: sojourn of pineapple from food to nanomedicine.10.1007/s40199-025-00585-8
- 2025Deciphering the iridoids' boundaries: from soil ecology to anti-inflammatory medicines.10.1007/s10787-025-01893-w
- 2025Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets.10.1007/s10787-025-01964-y
- 2024Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders.10.3389/fmed.2024.1463976
- 2024Mentha aquatica (Water Mint) as a Source of Active Pharmaceutical and Cosmetic Ingredients: A Critical Review.10.1002/ptr.8337
- 2024From nature's bounty to drug discovery: Leveraging phytochemicals and molecular approaches to combat multi-drug-resistant (MDR) tuberculosis.10.1016/j.ijtb.2023.08.007
- 2023Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.10.3390/ph16020197
- 2023Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources.10.2147/dmso.s390741
- 2023Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management.10.3389/fphar.2023.1182937
- 2022Gut Dysbiosis and Diabetic Foot Ulcer: Role of Probiotics.10.3390/pharmaceutics14112543
- 2022Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma.10.1007/s11356-022-21454-w
- 2022Sweet pepper and its principle constituent capsiate: functional properties and health benefits.10.1080/10408398.2021.1913989
- 2022Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine.10.1016/j.jep.2022.115144
- 2022Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties.10.3390/molecules27165219
- 2020Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.10.2174/1381612826666200826164322